Translational Genomics Institute — Phoenix, Arizona

Translational Genomics Institute is a clinical research site located in Phoenix, Arizona, United States 85004.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Translational Genomics Institute has participated in 1 clinical trials.

Therapeutic areas: Metastatic Solid Tumors, Refractory/Relapsed Hematologic Malignancies.

Sponsors: ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA).

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Translational Genomics Institute?

Translational Genomics Institute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Translational Genomics Institute conducted?

Translational Genomics Institute has 1 clinical trials on record. Their work covers Metastatic Solid Tumors, Refractory/Relapsed Hematologic Malignancies.

Is Translational Genomics Institute accredited by Crixeo Health?

Translational Genomics Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Translational Genomics Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.